JCI - Citations to Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

Citations to this article

Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

P Meissner, … , P Adams, R Kirsch

P Meissner, … , P Adams, R Kirsch

Published April 1, 1993
Citation Information: J Clin Invest. 1993;91(4):1436-1444. https://doi.org/10.1172/JCI116348.

View: Text | PDF

Research Article

Total citations by year

Year:	2021	2020	2019	2018	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	Total
Citations:	7	1	3	3	3	1	2	2	1	3	1	1	1	1	1	1	1	1	2	1	2	2	3	1	2	47

Citation information

Citations to this article (47)

Title and authors	Publication	Year
Laboratory Diagnosis of Porphyria ED Pierro, MD Canio, R Mercadante, M Savino, F Granata, D Tavazzi, AM Nicolli, A Trevisan, S Marchini, S Fustinoni	Diagnostics	2021
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks D Jericó, KM Córdoba, L Jiang, C Schmitt, M Morán, A Sampedro, M Alegre, M Collantes, E Santamaría, E Alegre, C Culerier, AE de Mendoza, J Oyarzabal, MA Martín, I Peñuelas, MA Ávila, L Gouya, PG Martini, A Fontanellas	Molecular Therapy — Nucleic Acids	2021
Novel treatment options for acute hepatic porphyrias B Wang	Current Opinion in Gastroenterology	2021
Unexpected presentation of acute porphyria CK Kiew, AS Lam	BMJ case reports	2021
Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks N Wilson-Baig, M Badminton, D Schulenburg-Brand		2021
Treatment with assisted reproduction technologies in women with acute hepatic porphyria D Vassiliou, AL Hirschberg, E Sardh	Acta Obstetricia et Gynecologica Scandinavica	2021
The acute hepatic porphyrias B Wang	Translational Gastroenterology and Hepatology	2021
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria HJ Bustad, K Toska, C Schmitt, M Vorland, L Skjærven, JP Kallio, S Simonin, P Letteron, J Underhaug, S Sandberg, A Martinez	Molecular Therapy	2020
Clinical Guide and Update on Porphyrias U Stölzel, MO Doss, D Schuppan	Gastroenterology	2019
Not Your Ordinary Rash GR Williams, RD Nerenz	Clinical chemistry	2019
Acute hepatic porphyrias: Current diagnosis & management KE Anderson	Molecular Genetics and Metabolism	2019
Porphyrien – was ist gesichert? U Stölzel, I Kubisch, T Stauch	Der Internist	2018
Porphyrias and photosensitivity: pathophysiology for the clinician L Kakoullis, S Louppides, E Papachristodoulou, G Panos	Postgraduate Medicine	2018
Molecular analysis of 19 Spanish patients with mixed porphyrias MJ Corte, FJ Rubio, MJ Jiménez, SD Díaz, FJ Fernandez, I García, RE de Salamanca, M Méndez	European Journal of Medical Genetics	2018
Inborn Metabolic Diseases JM Saudubray, MR Baumgartner, J Walter	Inborn Metabolic Diseases	2016
Update review of the acute porphyrias PE Stein, MN Badminton, DC Rees	British Journal of Haematology	2016
Red-Brown Urine in a Patient with Chronic HIV Infection and Quadriparesis NM Oosthuizen, J Olivier, J Martins, C Schutte, TS Pillay	Clinical chemistry	2016
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease R Schiffmann	Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease	2015
The Cutaneous Porphyrias D Schulenburg-Brand, R Katugampola, AV Anstey, MN Badminton	Dermatologic Clinics	2014
Management of acute intermittent porphyria P Harper, E Sardh	Expert Opinion on Orphan Drugs	2014
Partial protoporphyrinogen oxidase (PPOX) gene deletions, due to different Alu-mediated mechanisms, identified by MLPA analysis in patients with variegate porphyria M Barbaro, M Kotajärvi, P Harper, Y Floderus	Orphanet Journal of Rare Diseases	2013
Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients MD Ferrer, P Tauler, A Sureda, C Palacín, JA Tur, A Pons	European Journal of Clinical Investigation	2013
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics EJ Lamb, CP Price	Tietz Textbook of Clinical Chemistry and Molecular Diagnostics	2012
Handbook of Clinical Neurology T Ashizawa, PS Sarkar	Muscular Dystrophies	2011
Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria M Barbaro, M Kotajärvi, P Harper, Y Floderus	Clinical Genetics	2011
The neurologic manifestations of the acute porphyrias NG Simon, GK Herkes	Journal of Clinical Neuroscience	2011
Rook's Textbook of Dermatology JA McGrath, J Uitto	Rook's Textbook of Dermatology	2010
Tetrapyrroles MJ Warren, AG Smith		2009
Dominant versus recessive: Molecular mechanisms in metabolic disease J Zschocke	Journal of Inherited Metabolic Disease	2008
Class 2 · Transferases VI D Schomburg, I Schomburg, A Chang		2007
Biosynthesis of heme in mammals RS Ajioka, JD Phillips, JP Kushner	Biochimica et Biophysica Acta (BBA) - Molecular Cell Research	2006
The Porphyrin Handbook PM Shoolingin-Jordan	The Porphyrin Handbook	2003
Clinical and biochemical characteristics and genotype–phenotype correlation in Finnishvariegate porphyria patients M Fraunberg, K Timonen, P Mustajoki, R Kauppinen	European Journal of Human Genetics	2002
Celiac disease in patients with variegate porphyria. Twaddle S, Wassif WS, Deacon AC, Peters TJ	Digestive Diseases and Sciences	2001
Multiple Regulatory Steps in Erythroid Heme Biosynthesis SI Woodard, HA Dailey	Archives of Biochemistry and Biophysics	2000
Erythropoietic and hepatic porphyrias U Gross, GF Hoffmann, MO Doss	Journal of Inherited Metabolic Disease	2000
Peroxidizing Herbicides P Böger, K Wakabayashi		1999
Clinical Features of the Porphyrias MB MD	Clinics in Dermatology	1998
Molecular analysis reveals a high mutation frequency in the first untranslated exon of the PPOX gene and largely excludes variegate porphyria in a subset of clinically affected Afrikaner families MJ Kotze, JN Villiers, JZ Groenewald, RN Rooney, O Loubser, R Thiart, CJ Oosthuizen, MM Niekerk, IM Groenewald, AE Retief, L Warnich	Molecular and Cellular Probes	1998
Rat Harderian Gland Porphobilinogen Deaminase: Characterization Studies and Regulatory Action of Protoporphyrin IX CA Cardalda, AA Juknat, FG Princ, A Batlle	Archives of Biochemistry and Biophysics	1997
Herbicide-induced experimental variegate prophyria in mice: tissue porphyrinogen accumulation and response to porphyrogenic drugs J Krijt, P Stranska, P Maruna, M Vokurka, J Sanitrak	Canadian Journal of Physiology and Pharmacology	1997
Mapping of the variegate porphyria (VP) gene: Contradictory evidence for linkage between VP and microsatellite markers at chromosome 14q32 L Warnich, PN Meissner, RJ Hift, JH Louw, CJ Heerden, AE Retief	Human Genetics	1996
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria PN Meissner, TA Dailey, RJ Hift, M Ziman, AV Corrigall, AG Roberts, DM Meissner, RE Kirsch, HA Dailey	Nature Genetics	1996
Mapping of the variegate porphyria (VP) gene: contradictory evidence for linkage between VP and microsatellite markers at chromosome 14q32. Warnich L, Meissner PN, Hift RJ, Louw JH, van Heerden CJ, Retief AE	Human Genetics	1996
Diseases of metabolism (porphyrias) NA McCarroll	Analytical Chemistry	1995
Porphyrias: Clinical Evaluation and Interpretation of Laboratory Tests A Tefferi, LA Solberg, RD Ellefson	Mayo Clinic Proceedings	1994
Acute Porphyrias: Diagnosis and Management A Tefferi, JP Colgan, LA Solberg	Mayo Clinic Proceedings	1994

Advertisement